Amanote Research
Register
Sign In
202. A Chemotherapy-Selective Method for Expansion of Transgenic T Cells
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)34537-3
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2013
Authors
Unknown
Publisher
Elsevier BV
Related search
Expansion of Natural Killer Cells but Not T Cells in Human Interleukin 2/Interleukin 2 Receptor (Tac) Transgenic Mice
Journal of Experimental Medicine
Medicine
Allergy
Immunology
Selective Protection of Normal Cells During Chemotherapy by RY4 Peptides
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
A Novel Method for Expansion and Differentiation of Mouse Tracheal Epithelial Cells in Culture
Scientific Reports
Multidisciplinary
Role of Natural Killer T Cells in Immunogenic Chemotherapy for Breast Cancer
Elucidating the Mechanism of Action of Domatinostat (4sc-202) in Cutaneous T Cell Lymphoma Cells
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
68PPeptide-MHC-Directed Expansion of Multifunctional Antigen-Responsive T Cells
Annals of Oncology
Medicine
Oncology
Hematology
Clonal Expansion of Human T Lymphocytes Initiated by Dendritic Cells
Journal of Experimental Medicine
Medicine
Allergy
Immunology
Identification of a Selective RORγ Ligand That Suppresses TH17 Cells and Stimulates T Regulatory Cells
ACS Chemical Biology
Biochemistry
Medicine
Molecular Medicine
Positive and Negative Selection of T Cells in T-Cell Receptor Transgenic Mice Expressing a BCL-2 Transgene.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
